Evidence map›Paper›PMID 30707614›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2019

The renin-angiotensin system: going beyond the classical paradigms.

Robson Augusto Souza Santos, Gavin Y Oudit, Thiago Verano-Braga, Giovanni Canta, Ulrike Muscha Steckelings, Michael Bader

Open access · bronzeAbstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 163 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
163citing papers in PubMed, 4 pooled it
28.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

163 citing papers in PubMed, 4 syntheses or guidelines pooled it, 341 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Transient Increase in ATInternational journal of molecular sciences · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Ace2 safeguards embryonic hematopoietic stem and progenitor cell production by restraining Nlrp3-mediated pyroptosis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article

103 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Robson Augusto Souza SantosNational Institute of Science and Technology in Nanobiopharmaceutics, Department of Physiology and Biophysics, Federal University of Minas Gerais , Belo Horizonte, Minas Gerais , Brazil.ORCID 0000-0001-8738-5852
Gavin Y OuditDivision of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute, University of Alberta , Edmonton , Canada.
Thiago Verano-BragaNational Institute of Science and Technology in Nanobiopharmaceutics, Department of Physiology and Biophysics, Federal University of Minas Gerais , Belo Horizonte, Minas Gerais , Brazil.
Giovanni CantaNational Institute of Science and Technology in Nanobiopharmaceutics, Department of Physiology and Biophysics, Federal University of Minas Gerais , Belo Horizonte, Minas Gerais , Brazil.
Ulrike Muscha SteckelingsDepartment of Molecular Medicine, Cardiovascular & Renal Research, University of Southern Denmark, Odense, Denmark.
Michael BaderMax Delbrück Center for Molecular Medicine , Berlin , Germany.
Universidade Federal de Minas Gerais · BRMax Delbrück Center · DEUniversity of Alberta · CAUniversity of Southern Denmark · DK

Funding

CIHR
6 · The paper itself

Abstract

Thirty years ago, a novel axis of the renin-angiotensin system (RAS) was unveiled by the discovery of angiotensin-(1-7) [ANG-(1-7)] generation in vivo. Later, angiotensin-converting enzyme 2 (ACE2) was shown to be the main mediator of this reaction, and Mas was found to be the receptor for the heptapeptide. The functional analysis of this novel axis of the RAS that followed its discovery revealed numerous protective actions in particular for cardiovascular diseases. In parallel, similar protective actions were also described for one of the two receptors of ANG II, the ANG II type 2 receptor (AT

Indexed as

Renin-Angiotensin SystemSignal TransductionAngiotensin-Converting Enzyme 2Angiotensin IAnimalsCardiovascular AgentsCardiovascular DiseasesCardiovascular SystemCongresses as TopicHumansOligopeptidesPeptide FragmentsPeptidyl-Dipeptidase AReceptor, Angiotensin, Type 2Receptors, G-Protein-CoupledACE2 protein, humanAGTR2 protein, humanalamandineAngiotensin-Converting Enzyme 2Angiotensin Iangiotensin I (1-7)Cardiovascular AgentsMRGPRD protein, humanOligopeptidesPeptide FragmentsPeptidyl-Dipeptidase AReceptor, Angiotensin, Type 2Receptors, G-Protein-Coupledalamandineangiotensin-(1−7)angiotensin-(1−9)angiotensin-converting enzyme 2heart failure

Identifiers

PMID30707614
PMCPMC7191626
OpenAlexW2914853620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.